Overview
Status
Active
Registry date
2023-02-02
Share capital
5,000.00 PLN
Registered address
ul. Kard. Stefana Wyszyńskiego 5, 21-542 Leśna Podlaska, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 106 days early. All were audited by a statutory auditor.
- 202523/02/2026
- 202410/03/2025
- 202328/05/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.04mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -2.45kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 2.03mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 1.20mMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Andrzej Kamiński – President of the Management Board
Leszek Andrzej Włos – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Kamińskiage 68 | 25 | $675.31 | 50% |
Leszek Andrzej Włosage 58 | 25 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-02-10.
26 1090 2590 0000 0001 5675 9580
60 1090 2590 0000 0001 5675 9550
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| PetnovellS.A. | $0.00 | petnovell.pl | ||
| Dental Łukasiksp. j. | – | dental.lublin.pl |
FAQ
The main business activity of Leś-Med focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 2, 2023.
The headquarters is located at: ul. Kard. Stefana Wyszyńskiego 5, 21-542 Leśna Podlaska.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $2,041,338 in 2025, which is an increase of 42.2% compared to 2024.
No, the company recorded a net loss of $2,455 in 2025. For comparison, in 2024 the loss was $434, meaning the company increased its loss by 464.4%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,026,276 in 2025, representing 100% of all operating expenses.
Last updated: 2026-04-20